INNOVA BIOCARE SL
Company details
- Active NIF/CIF: B90294802
-
-
-
-
Address: Av. de la Buhaira, 29, 41018 Sevilla, España See in map
-
-
Featured products:
More information on INNOVA BIOCARE SL
-
16/12/2024 | BORME act no.: 544656 | Register: SEVILLACeses/Dimisiones
-
16/12/2024 | BORME act no.: 544656 | Register: SEVILLANombramientos
-
16/12/2024 | BORME act no.: 544656 | Register: SEVILLAModificaciones estatutarias
-
16/12/2024 | BORME act no.: 544656 | Register: SEVILLAOtros conceptos
-
05/10/2020 | BORME act no.: 335216 | Register: SEVILLAModificaciones estatutarias
-
05/10/2020 | BORME act no.: 335216 | Register: SEVILLACambio de domicilio social
-
01/12/2016 | BORME act no.: 488104 | Register: SEVILLAConstitución
-
01/12/2016 | BORME act no.: 488104 | Register: SEVILLANombramientos
Other information
The CIF assigned to INNOVA BIOCARE SL is B90294802, and its business status is active. The company is engaged in an economic activity classified within the CNAE 4645 - Comercio al por mayor de productos perfumería y cosmética. In addition, its SIC identification - also defines it.
INNOVA BIOCARE SL employs a team of Between 1 and 9 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Sevilla, and has 4 executive positions. Its most recent announcement in the Borme was published on 16/12/2024, while its last deposit of ordinary annual accounts is for the 2023 fiscal year.
To access the contact information of INNOVA BIOCARE SL, such as the telephone number, postal address, or website, visit the Company Data module.
If you require more details about INNOVA BIOCARE SL, we invite you to consult one of our available financial reports, the company's Annual Accounts, or to check its payment incidents in the RAI delinquency file.
The financial, business, and legal information provided about INNOVA BIOCARE SL is extracted from official sources and is updated daily.
Do you want to know more about INNOVA BIOCARE SL??
Find out more about this company by consulting these reports: